129 related articles for article (PubMed ID: 33735799)
1. Synthesis and evaluation of novel thiosemicarbazone and semicarbazone analogs with both anti-proliferative and anti-metastatic activities against triple negative breast cancer.
Bai C; Wu S; Ren S; Zhu M; Luo G; Xiang H
Bioorg Med Chem; 2021 May; 37():116107. PubMed ID: 33735799
[TBL] [Abstract][Full Text] [Related]
2. Rationally designed hecogenin thiosemicarbazone analogs as novel MEK inhibitors for the control of breast malignancies.
Elsayed HE; Ebrahim HY; Haggag EG; Kamal AM; El Sayed KA
Bioorg Med Chem; 2017 Dec; 25(24):6297-6312. PubMed ID: 29066046
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of isoflavene-thiosemicarbazone hybrids and evaluation of their anti-tumor activity.
Yee EMH; Brandl MB; Black DS; Vittorio O; Kumar N
Bioorg Med Chem Lett; 2017 Jun; 27(11):2454-2458. PubMed ID: 28408225
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway.
Peng B; He R; Xu Q; Yang Y; Hu Q; Hou H; Liu X; Li J
Pharmacol Res; 2019 Apr; 142():1-13. PubMed ID: 30735802
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative and antimetastatic properties of 3-benzyloxy-16-hydroxymethylene-estradiol analogs against breast cancer cell lines.
Sinka I; Kiss A; Mernyák E; Wölfling J; Schneider G; Ocsovszki I; Kuo CY; Wang HC; Zupkó I
Eur J Pharm Sci; 2018 Oct; 123():362-370. PubMed ID: 30010030
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Elkhalifa D; Siddique AB; Qusa M; Cyprian FS; El Sayed K; Alali F; Al Moustafa AE; Khalil A
Eur J Med Chem; 2020 Feb; 187():111954. PubMed ID: 31838326
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
[TBL] [Abstract][Full Text] [Related]
9. Semicarbazone Derivatives Bearing Phenyl Moiety: Synthesis, Anticancer Activity, Cell Cycle, Apoptosis-Inducing and Metabolic Stability Study.
Ma J; Ni X; Gao Y; Huang K; Wang Y; Liu J; Gong G
Chem Pharm Bull (Tokyo); 2019 Apr; 67(4):351-360. PubMed ID: 30674756
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 4'-O-alkylamino-tethered-benzylideneindolin-2-ones as potent cytotoxic and apoptosis inducing agents.
Senwar KR; Reddy TS; Thummuri D; Sharma P; Bharghava SK; Naidu VG; Shankaraiah N
Bioorg Med Chem Lett; 2016 Aug; 26(16):4061-9. PubMed ID: 27397498
[TBL] [Abstract][Full Text] [Related]
11. Discovery of a novel small-molecule inhibitor of Fam20C that induces apoptosis and inhibits migration in triple negative breast cancer.
Zhao R; Fu L; Yuan Z; Liu Y; Zhang K; Chen Y; Wang L; Sun D; Chen L; Liu B; Zhang L
Eur J Med Chem; 2021 Jan; 210():113088. PubMed ID: 33316691
[TBL] [Abstract][Full Text] [Related]
12. Pyoluteorin induces cell cycle arrest and apoptosis in human triple-negative breast cancer cells MDA-MB-231.
Ding T; Yang LJ; Zhang WD; Shen YH
J Pharm Pharmacol; 2020 Jul; 72(7):969-978. PubMed ID: 32246778
[TBL] [Abstract][Full Text] [Related]
13. Apatinib enhanced anti-tumor activity of cisplatin on triple-negative breast cancer through inhibition of VEGFR-2.
Gao Z; Shi M; Wang Y; Chen J; Ou Y
Pathol Res Pract; 2019 Jul; 215(7):152422. PubMed ID: 31079851
[TBL] [Abstract][Full Text] [Related]
14. Tryptophan hydroxylase 1 and 5-HT
Gautam J; Banskota S; Regmi SC; Ahn S; Jeon YH; Jeong H; Kim SJ; Nam TG; Jeong BS; Kim JA
Mol Cancer; 2016 Nov; 15(1):75. PubMed ID: 27871326
[TBL] [Abstract][Full Text] [Related]
15. Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells.
Zhou Y; Lin S; Tseng KF; Han K; Wang Y; Gan ZH; Min DL; Hu HY
BMC Cancer; 2016 Oct; 16(1):818. PubMed ID: 27769200
[TBL] [Abstract][Full Text] [Related]
16. SSi6 promotes cell death by apoptosis through cell cycle arrest and inhibits migration and invasion of MDA-MB-231 human breast cancer cells.
Luna-Dulcey L; da Silva JA; Cominetti MR
Anticancer Drugs; 2020 Jan; 31(1):35-43. PubMed ID: 31490285
[TBL] [Abstract][Full Text] [Related]
17. Novel Steroidal 5α,8α-Endoperoxide Derivatives with Semicarbazone/Thiosemicarbazone Side-chain as Apoptotic Inducers through an Intrinsic Apoptosis Pathway: Design, Synthesis and Biological Studies.
Ma L; Wang H; Wang J; Liu L; Zhang S; Bu M
Molecules; 2020 Mar; 25(5):. PubMed ID: 32156024
[TBL] [Abstract][Full Text] [Related]
18. Novel sesquiterpene lactone analogues as potent anti-breast cancer agents.
Nakagawa-Goto K; Chen JY; Cheng YT; Lee WL; Takeya M; Saito Y; Lee KH; Shyur LF
Mol Oncol; 2016 Jun; 10(6):921-37. PubMed ID: 27055598
[TBL] [Abstract][Full Text] [Related]
19. Novel thiosemicarbazones induce high toxicity in estrogen-receptor-positive breast cancer cells (MCF7) and exacerbate cisplatin effectiveness in triple-negative breast (MDA-MB231) and lung adenocarcinoma (A549) cells.
Medina-Reyes EI; Mancera-Rodríguez MA; Delgado-Buenrostro NL; Moreno-Rodríguez A; Bautista-Martínez JL; Díaz-Velásquez CE; Martínez-Alarcón SA; Torrens H; de Los Ángeles Godínez-Rodríguez M; Terrazas-Valdés LI; Chirino YI; Vaca-Paniagua F
Invest New Drugs; 2020 Jun; 38(3):558-573. PubMed ID: 31177399
[TBL] [Abstract][Full Text] [Related]
20. One-pot three-component synthesis of novel spirooxindoles with potential cytotoxic activity against triple-negative breast cancer MDA-MB-231 cells.
Eldehna WM; El-Naggar DH; Hamed AR; Ibrahim HS; Ghabbour HA; Abdel-Aziz HA
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):309-318. PubMed ID: 29281924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
